4/A
Changes in Ownership
OptimizeRx Corp Filed Acc 0001628280-25-058715
Chief Finance & Strat Officer gave up 1,388 shares (to pay taxes)
- Chief Finance & Strat Officer acquired 5,237 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Stelmakh Edward Chief Finance & Strat Officer | 2025-12-19 | Option exercise | +5,237 | 128,218 | D: show line 1 in the form | ||
| Stelmakh Edward Chief Finance & Strat Officer | 2025-12-19 | Shares withheld for taxes | −1,388 | $13.51 | $18,752 | 126,830 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Stelmakh Edward Chief Finance & Strat Officer | 2025-12-19 | Option exercise · Restricted Stock Units | −5,237 | 5,237 | D: show line 3 in the form |
Loading xslF345X05/wk-form4a_1766517784.xml…